NVO - Pharmaceutical Crime Jumps 50% As Criminals Seek To Capitalize Rising Tide of Counterfeit Weight-Loss Drugs | Benzinga
As the weight-loss frenzy fueled by social media endorsements and Hollywood glamour continues to surge, the battle against counterfeit medications has intensified.
The allure of quick fixes for weight loss has spawned a lucrative market for counterfeit drugs, mimicking the likes of Novo Nordisk A/S’s (NYSE:NVO) Ozempic and Wegovy, both containing semaglutide.
With supply shortages exacerbating the demand, criminals have capitalized on the opportunity, flooding the market with potentially deadly concoctions.
The U.K.’s Medicines and Healthcare Products Regulatory Agency criminal enforcement team has seized thousands of fake medications, including insulin-filled pens disguised as Ozempic indicated for diabetes.
The surge in counterfeit drugs isn’t confined to ...